Nuclear Medicine & Radiopharmaceuticals Market Size & Share Analysis 2034 According to a newly published market research report by 24LifeSciences, the global nuclear medicine & radiopharmaceuticals market was valued at USD 5.59 billion in 2024 and is projected to reach USD 9.61 billion by 2031, growing at a compound annual growth rate (CAGR) of 7,9% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7243/nuclear-medicine-radiopharmaceuticals-market

Global Surgical Instrument Tracking System Market to Reach USD 606 Billion by 2032 | CAGR 16.4 X% According to a newly published market research report by 24LifeSciences, the global surgical instrument tracking system market was valued at USD 215 million in 2024 and is projected to reach USD 606 million by 2031, growing at a compound annual growth rate (CAGR) of 16,4% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7305/surgical-instrument-tracking-system-market

Non- Alcoholic Steatohepatitis Treatment Market Analysis 2034 | Regional Trends According to a newly published market research report by 24LifeSciences, global Non-Alcoholic Steatohepatitis Treatment market was valued at USD 1.8 billion in 2024 and is projected to reach USD 24.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 39.5% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9704/non-alcoholic-steatohepatitis-treatment-market

Test Phantoms MarketSize & Share Analysis 2032 According to a newly published market research report by 24LifeSciences, global test phantoms market was valued at USD 192 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3,8% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7659/test-phantoms-market

Dynamic Mechanical Analyzer (DMA) Market Analysis 2032 | Regional Trends According to a newly published market research report by 24LifeSciences, global Dynamic Mechanical Analyzer (DMA) market was valued at USD 64.2 million in 2024 and is projected to reach USD 88.8 million by 2031, growing at a compound annual growth rate (CAGR) of 4,9% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7227/dynamic-mechanical-analyzer-dma-market

Mitochondrial Membrane Potential Fluorescent Probes Market Analysis 2034 | Regional Trends According to a newly published market research report by 24LifeSciences, global mitochondrial membrane potential fluorescent probes market was valued at USD 283.5 million in 2024 and is projected to reach USD 478.2 million by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11416/mitochondrial-membrane-potential-fluorescent-probes-market

Global Secukinumab Market to Reach USD 7.8 Billion by 2032 | CAGR 6.8% According to a newly published market research report by 24LifeSciences, the global secukinumab market was valued at USD 4.5 billion in 2024 and is projected to reach USD 7.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6,8% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9981/secukinumab-market

GLP-1 Market Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035 Roots Analysis recently published a report on the global GLP-1 Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories. Market Size and Forecast Current Market Size:USD 101.4 Billion Future Market Size: USD 180 Billion CAGR: 8.7% Market Overview This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments. This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration. Market Scope and Segmentation - Historical Trend: Since 2020 - Forecast Period: Till 2035 - Market Size 2026: USD 101.4 Billion - Market Size 2035: USD 180 Billion - CAGR (Till 2035): 8.7% - Segments Covered • Type of Molecule • Active Compound Used • Type of GLP 1 Agonist Drugs • GLP 1 Agonist • Target Indication • Geographical Regions Read More: https://www.rootsanalysis.com/reports/glp-1-market.html By Region This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities. Technological and Strategic Insights The Roots Analysis report includes a detailed assessment of: Technological advancements and R&D activity Innovations in formulation and delivery methods Marketing and distribution strategies Pricing models and cost structures Manufacturing capacities and supply chain trends These insights are presented neutrally, supported by empirical evidence and primary research validation. Key Market Players Profiles of prominent companies include: AstraZeneca, Biolingus, Boehringer Ingelheim, D&D Pharmatech, Eli Lilly, Gmax Biopharm, Hanmi Pharmaceutical, Innogen, Novo Nordisk, PegBio, Pfizer, QL Biopharma, Roche, Sanofi, Sciwind Biosciences, Tonghua Dongbao Pharmaceutical, Viking Therapeutics, Vivani, vTv Therapeutic Each profile highlights: Product portfolio and focus areas Operational footprint and regional presence Financial and strategic performance Recent developments (e.g., partnerships, market entries, acquisitions) Regional Insights Each region is analyzed based on: Historical and current market size Revenue performance Contribution to global share Strategic developments and regional trends Comparative insights across regions enable targeted market entry and expansion strategies. Report Structure Part 01: Market Overview Part 02: Market Size, by Regions Part 03: Market Revenue, by Countries Part 04: Market Competition, by Key Players Part 05: Company Profiles

What Is the Future of Portable Electrosurgery Analyzers Market? 2026–2034 Outlook According to a newly published market research report by 24LifeSciences, global portable electrosurgery analyzers market was valued at USD 312.5 million in 2024 and is projected to reach USD 485.7 million by 2032, growing at a compound annual growth rate (CAGR) of 5,8% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10047/portable-electrosurgery-analyzers-market

Compounded Pet Medications Market Outlook: Opportunities & Trends According to a newly published market research report by 24LifeSciences, global compounded pet medications market was valued at USD 2.8 billion in 2024 and is projected to reach USD 5.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10515/compounded-pet-medications-market